Solitary plasmacytoma of skull is rare disease and considered to be curable with resection & radiotherapy. 4 Due to its rarity most of the time preoperatively it is misdiagnosed as meningioma or metastasis. As compared to SPB the prognosis of solitary plasmacytoma of skull is good if it is diagnosed on strict criteria. 1 So making the appropiate diagnosis is necessary for further management & follow up, though from some literature they think that solitary plasmacytoma is the initial presentation of multiple myeloma with progression of time this may convert into multiple myeloma. 5 We go through published literature [Table: 1(4,6-12)] of patients diagnosed as a case of solitary plasmacytoma of skull received enbloc removal of tumor including cranioplasty. All of those patients are histopathologically proven plasmacytoma of skull among them four patients receive only surgery, no post operative radiotherapy or chemotherapy, and four patients received surgery along with post operative radiotherapy, and on follow up among them seven patient has no recurrence except one patient whom post operative follow up is not avialable.
Radiotherapy is the definitive treatment for solitary plasmacytoma of bone, surgery along with radiotherapy is the treatment of choice based on tumor location and type of removal of tumor, chemotherapy is not needed until there is systemic involvement as like multiple myeloma. 4 if there is gross total resection of tumor incase of isolated local tumor radiotherapy is needed or not is still in quary, but as sometimes solitary plasmacytoma is the initial presentation of multiple myeloma regular follow up is necessary in all cases.
Conclusion:
Isolated solitary plasmacytoma is a very rare tumor, enbloc tumor removal with removal of involved bone and dura upto macroscopic healthy margin with cranioplasty and duroplasty is a treatment option as histopathology report reveals margin is free from tumor, so no radiotherapy is required but regular follow up should be carried out.
